UNSPSC 41202016: Cytomegalovirus serological reagents

In this classification, Cytomegalovirus serological reagents are devices used in test to identify specific Cytomegalovirus antibodies in serum. US FDA regulates Cytomegalovirus serological reagents under 21 CFR 866.3175 and under FDA product code GQH.

UNSPSC 41202016 Cytomegalovirus serological reagents (Commodity) comprises laboratory reagents and test kits used by state and local health departments, county criminal-justice and public-health agencies, and cities to diagnose, screen, and monitor infectious diseases through blood and specimen analysis. Recent opportunities show state and local procurement under this code focuses on rapid diagnostic test kits, reagent supplies for automated laboratory analyzers, and associated controls and calibrators. The Illinois Department of Public Health, the City of Austin, Collin County (Texas), and Gwinnett County (Georgia) have solicited supplies in this category over the past five months, spanning STI testing (gonorrhea/chlamydia and syphilis), HIV screening, drug-testing analytics, and general clinical laboratory services. The issuing bodies include state departments of health and criminal justice, county community supervision and corrections departments, county health-care services, county jails, and city public-health programs—a mix reflective of disease surveillance and criminal-justice monitoring mandates across government.

Activity concentrates in Texas and Illinois, with additional solicitation in Georgia. Representative opportunities include the Illinois Department of Public Health's change order (Contract 68500013N, increase of $375,000 over five years for Hologic NG/NT testing kits and collection supplies due October 13, 2026) and the City of Austin's two sequential HIV test-kit IFBs (375 Abbott Determine test kits and 79 control kits annually, due July 17 and September 3, 2026). Collin County issued an RFP for offender drug-testing services (approximately 25,031 annual tests, $600,000 estimated value, due July 23, 2026) and a separate IFB for general laboratory services (approximately $70,000 annual value, due October 2, 2025). Illinois Department of Public Health also conducted emergency sole-source procurements with Abbott Laboratories for HIV/Syphilis reagents ($38,079.50, due August 18, 2026) driven by CLIA compliance and test-system continuity. Recent opportunities emphasize vendor compliance with CLIA and state lab certifications, all-inclusive pricing with no surcharges, electronic result reporting, and turnaround-time performance standards.